JohnTimothyStoutMD
Ophthalmology • Houston, TXProfessor, Ophthalmology, Oregon Health and Science University School of Medicine
Are you Dr. Stout?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 72 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1504 Taub Loop
Houston, TX 77030Phone+1 713-526-4243Fax+1 713-798-4364
Summary
- Dr. John Stout, MD is a board certified ophthalmologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Oregon, and California. He is affiliated with St. Luke's Health - Baylor St. Luke's Medical Center, Texas Children's Hospital, and Harris Health System.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1990 - 1995
Baylor College of MedicineInternship, Transitional Year, 1989 - 1990- Baylor College of MedicineClass of 1989
Certifications & Licensure
OR State Medical License 2000 - Present
CA State Medical License 1990 - 2026
TX State Medical License 2013 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis Start of enrollment: 2009 Jun 17
Publications & Presentations
PubMed
- 44 citationsCombination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome.Steven Yeh, Eric B. Suhler, Justine R. Smith, Beau B. Bruce, Gary A. Fahle
Ophthalmic Surgery, Lasers & Imaging Retina. 2014-09-01 - 35 citationsNatural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten
Ophthalmology. 2019-02-01 - 41 citationsResults at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.Mark E. Pennesi, Richard G. Weleber, Paul Yang, Chris Whitebirch, Beverly Thean
Human Gene Therapy. 2018-12-13
Professional Memberships
- Fellow
- Member
